We conclude that STMN1, an essential protein for tumorigenic growth and cell-cycle progression, is inhibited by T3 at the transcriptional level, reflecting the negative correlation between the expression patterns of these proteins in clinical liver cancer specimens. The gene discussed is STMN1; the disease is liver cancer.